Nithyanandan Thangavelu

Title: Nithyanandan Thangavelu: Innovator in Machine Learning for Clinical Trials

Introduction

Nithyanandan Thangavelu is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of machine learning, particularly in the evaluation of clinical trial data. His innovative approach aims to enhance the accuracy and efficiency of clinical investigations.

Latest Patents

Nithyanandan holds a patent for "Machine learning techniques for automatic evaluation of clinical trial data." This patent describes systems and methods that utilize machine-learning techniques to evaluate clinical trial data using one or more learning models trained to identify anomalies representing adverse events associated with a clinical trial investigation. The invention involves obtaining investigation data collected at a clinical trial site and selecting a set of models corresponding to that site. Each model is trained to identify distinct indicators that indicate a compliance risk associated with the investigation data. A score for the clinical trial site is determined based on the investigation data relative to historical investigation data, representing the likelihood that the investigation data is associated with at least one compliance risk indicator. Nithyanandan has 1 patent to his name.

Career Highlights

Nithyanandan is currently employed at IQVIA Inc., a leading company in the field of healthcare data analytics. His work focuses on leveraging machine learning to improve clinical trial processes and outcomes. His expertise in this area has positioned him as a valuable asset to his organization.

Collaborations

Nithyanandan collaborates with talented professionals in his field, including Rajneesh Patil and Virupaxkumar Bonageri. Together, they work on advancing the application of machine learning in clinical research.

Conclusion

Nithyanandan Thangavelu is a key figure in the intersection of machine learning and clinical trials. His innovative patent and contributions to the field demonstrate his commitment to improving healthcare through technology.